Indoco Remedies Limited INDOCO.NS · Stock Open Indoco Remedies Limited in new tab
Analyst price targets
Recent rating changes, newest first
Indoco Remedies Limited Analysis (INDOCO.NS)
Is Indoco Remedies Limited a good investment? Indoco Remedies Limited (INDOCO.NS) is currently trading at 226.55 INR. Market analysts have a consensus price target of 264.00 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 740.31. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Indoco Remedies Limited is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 12.15.
For income investors, Indoco Remedies Limited pays a dividend yield of 0.09%. With a payout ratio of 51%, the dividend appears sustainable.
Investor FAQ
Does Indoco Remedies Limited pay a dividend?
Yes, it pays an annual dividend of 0.20 INR (0.09% yield).
What asset class is Indoco Remedies Limited?
Indoco Remedies Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 0.32.
Company Profile
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; antacids; and antihistaminic, anti-inflammatory drugs, etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, extractables and leachables studies, and chromatographic method development and validation services. Further, the company offers architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. Additionally, it provides contract research services, such as custom chemical synthesis of molecules and intermediates; process chemistry research and development; non-infringing process designing and scale up; and analytical method development, validation, impurity characterization, and polymorphic studies, solutions, as well as intellectual property management. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
0.20 INR
|
| Oct. 17, 2026 | 0.2000 |
| ▸2025 |
0.20 INR
|
| Oct. 11, 2025 | 0.2000 |
| ▸2024 |
1.50 INR
|
| Oct. 26, 2024 | 1.5000 |
| ▸2023 |
2.25 INR
|
| Oct. 26, 2023 | 2.2500 |
| ▸2022 |
2.25 INR
|
| Sept. 27, 2022 | 2.2500 |
| ▸2021 |
1.50 INR
|
| Oct. 23, 2021 | 1.5000 |
| ▸2020 |
0.30 INR
|
| Oct. 24, 2020 | 0.3000 |
| ▸2019 |
0.30 INR
|
| Sept. 24, 2019 | 0.3000 |
| ▸2018 |
1.00 INR
|
| Oct. 11, 2018 | 1.0000 |
| ▸2017 |
1.60 INR
|
| Sept. 8, 2017 | 1.6000 |
| ▸2016 |
1.60 INR
|
| Aug. 28, 2016 | 0.2000 |
| May 1, 2016 | 1.4000 |
| ▸2015 |
1.60 INR
|
| Aug. 29, 2015 | 1.6000 |
| ▸2014 |
1.40 INR
|
| July 18, 2014 | 1.4000 |
| ▸2013 |
1.10 INR
|
| Aug. 29, 2013 | 1.1000 |
| ▸2012 |
1.10 INR
|
| Aug. 29, 2012 | 1.1000 |
| ▸2011 |
5.33 INR
|
| Aug. 27, 2011 | 5.3333 |
| ▸2010 |
4.67 INR
|
| Aug. 21, 2010 | 4.6667 |
| ▸2009 |
3.50 INR
|
| Oct. 18, 2009 | 1.3333 |
| Jan. 1, 2009 | 2.1667 |
| ▸2008 |
7.67 INR
|
| Nov. 1, 2008 | 3.3333 |
| Jan. 1, 2008 | 4.3333 |
| ▸2006 |
4.17 INR
|
| Nov. 1, 2006 | 4.1667 |
| ▸2005 |
3.33 INR
|
| Oct. 2, 2005 | 3.3333 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Indoco Remedies Limited | Oct 17, 2026 | Upcoming | 0.2 INR |
| Split Date | Split Ratio to 1 |
|---|---|
| May 17, 2012 | 5:1 |
Community Discussion